Key Highlights:
- Sanofi Healthcare India, a promoter-group entity of Sanofi, acquired 35 lakh shares, representing a 15.19% stake in Sanofi India, through an open-market transaction for approximately ₹1,068.2 crore.
- The shares were purchased at an average price of ₹3,052 apiece, while Hoechst GmbH, another Sanofi Group promoter entity, sold the equivalent number of shares at the same price.
- Following the transaction, Hoechst’s stake declined to 45.17% from 60.37%, while the combined shareholding of Sanofi India’s promoter group remained unchanged
Implications:
The transaction is an internal reshuffle within Sanofi’s promoter group, so it doesn’t change overall control or the free float, and therefore has limited direct market impact.
Source: ET Pharma
